Blog Post by Admin
Case Study
Apr 19, 2024
Case Study: Enhancing clinical trial data sharing with synthetic datasets
Unlock the future of research with our groundbreaking approach to privacy-preserving data ...
Start Reading
Case Study
Apr 19, 2024
Case Study. Data Guardian: Securing Enterprise Health Data through an Advanced Risk Assessment and De-Identification Solution
Our case study explores how our client, a leading American retail company, and its ...
Start Reading
Case Study
Apr 19, 2024
Case Study: Unlock the Replicability Power of Synthetic Data in Health Research – with Practical and Reliable Guidelines
Embark on a journey to harness the full potential of Synthetic Data Generation (SDG) ...
Start Reading
Whitepaper
Apr 19, 2024
Whitepaper: RWE as Confirmatory Evidence for Accelerated Approvals
Since 1992, the FDA has paved the way for life-saving medicines to reach patients swiftly ...
Start Reading
Publication
Mar 24, 2024
An evaluation of the replicability of analyses using synthetic health data
This paper published in Scientific Reports describes a study evaluating the replicability ...
Start Reading
Presentation
Dec 13, 2023
Ten Things I have Learned About Synthetic Data Generation
Khaled El Emam, SVP & GM, Replica Analytics
Start Reading
Presentation
Nov 30, 2023
Synthetic Data Summit 2023 | Session 2: Perspectives from Health Regulators
Title: High-Fidelity Synthetic Data Applications for Data Augmentation
Start Reading
Presentation
Nov 30, 2023
Synthetic Data Summit 2023 | Session 5: Applications in Complex Healthcare Settings
Title: Generating Synthetic Data for the NHS
Start Reading
Presentation
Nov 30, 2023
Synthetic Data Summit 2023 | Session 4: Applications of Synthetic Data in the Life Sciences Industry II
Title: Applications of Privacy Enhancing Technology to Data Sharing at a Global ...
Start Reading
Presentation
Nov 30, 2023
Synthetic Data Summit 2023 | Session 3: Applications of Synthetic Data in the Life Sciences Industry I
Title: Applications of Synthetic Data in Supporting Data Products and Analytics for Real ...
Start Reading
Presentation
Nov 30, 2023
Synthetic Data Summit 2023 | Welcome / Opening remarks
Speaker: Khaled El Emam GM and SVP, Replica Analytics; Professor, University of Ottawa
Start Reading
Presentation
Nov 30, 2023
Synthetic Data Summit 2023 | Session 1: Regulating Privacy Risks from Synthetic Data
Title: Assessing the Privacy Risks of Synthetic Data and Other PETs
Start Reading
Presentation
Nov 30, 2023
Synthetic Data Summit 2023 | Session 6: New Applications
Title: Assessing Utility and Building Industry Trust for Imaging Data in Healthcare
Start Reading
Presentation
Nov 30, 2023
Synthetic Data Summit 2023 | Closing Remarks
Speaker: Dorothee Bartels Chief Digital Officer, Aetion
Start Reading
Blog
Nov 16, 2023
Partnering to enhance Japanese RWD at a global scale: A Q&A with JMDC
JMDC, a leading Japanese health big data firm, and Aetion® recently announced a ...
Start Reading
Blog
Nov 8, 2023
Research Spotlight: Navigating Treatment Effectiveness in Rare Oncology with External Control Cohorts
Real-world data (RWD) has proven to be a pivotal tool in understanding patient treatment ...
Start Reading
Publication
Nov 1, 2023
Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets
This paper published in the Journal of Clinical Oncology: Clinical Cancer Informatics ...
Start Reading
Blog
Oct 23, 2023
What I saw at DIA RWE 2023
I am just back from Baltimore, Maryland, where I had the joy of attending DIA’s ...
Start Reading
Blog
Oct 19, 2023
Advancing RWE in Oncology with Aetion’s CARE Initiative
In late 2022, Aetion announced the launch of the Aetion Coalition to Advance Real‐World ...
Start Reading
Blog
Sep 1, 2023
What I saw at ICPE 2023
I just had the pleasure and privilege of attending the 39th International Conference on ...
Start Reading
Blog
Aug 29, 2023
Leveraging the SURF screening tool to understand how to identify whether RWE of effectiveness may be acceptable for regulatory decision-making for a clinical development program
Ulka Campbell, Ph.D., is Aetion’s Head of Scientific Strategy. In this role, she uses her ...
Start Reading
Publication
Aug 1, 2023
Consolidated Reporting Guidelines for Prognostic and Diagnostic Machine Learning Modeling Studies: Development and Validation.
The reporting of machine learning (ML) prognostic and diagnostic modeling studies is ...
Start Reading
Presentation
Aug 1, 2023
Demystifying HIPAA: Techniques for De-identifying Complex Multi-modal Data
Patricia Thaine, Co-Founder & CEO, Private AI
Start Reading
Publication
Jul 13, 2023
A comparison of synthetic data generation and federated analysis for enabling international evaluations of cardiovascular health
Our recent article in Scientific Reports entitled, A comparison of synthetic data ...
Start Reading